コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al = - 0.67 to 0.48, I(2) = 3.2) compared to euthyroidism.
2 lar mortality compared with individuals with euthyroidism.
3 ersal of the weight loss with restoration of euthyroidism.
4 ypothyroidism compared with individuals with euthyroidism.
5 ll patients achieve clinical and biochemical euthyroidism.
6 n; mean [SD] age, 57 [5.7] years), 93.0% had euthyroidism, 2.6% had subclinical hyperthyroidism, and
7 subclinical hypo- or hyperthyroidism versus euthyroidism, adjusting for depressive symptoms at basel
10 rapy was adjusted (50 mug per day) to induce euthyroidism and to achieve a target serum thyroid-stimu
11 erapy was adjusted (50 ug per day) to induce euthyroidism and to achieve a target serum thyroid-stimu
12 thyrotropin level higher than 5.1 mIU/L, and euthyroidism as a thyrotropin level of 0.56 to 5.1 mIU/L
13 were associated with worse Global gait than euthyroidism (beta = -0.61; CI = -1.03, -0.18; p = 0.004
15 idism or overt hypothyroidism groups and the euthyroidism group for cardiovascular outcomes or mortal
16 en the subclinical hyperthyroidism group and euthyroidism group for incident coronary heart disease,
17 d at baseline and 3 to 9 months later, after euthyroidism had been attained by L-thyroxine replacemen
18 ompensate for low iodine intake and maintain euthyroidism in most individuals, but at a price: chroni
19 mentation and the maintenance of biochemical euthyroidism may help to achieve an ultimate therapeutic
21 n test results: subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypo
22 me-varying serum thyrotropin and FT4 levels (euthyroidism: thyrotropin level, 0.5-5.5 mIU/L; FT4 leve
23 ings emphasize the importance of maintaining euthyroidism to decrease cardiovascular risk and death a